Up-regulation of asparagine synthetase expression is not linked to the clinical response L-asparaginase in pediatric acute lymphoblastic leukemia.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Blood

• Publication date

  2006-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1182/BLOOD-2005-06-2597PMID 16497975
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A genome-wide view of the in vitro response to l-asparaginase in acute lymphoblastic leukemia.

  2005cited by this paper
• Asparagine synthetase expression is linked with L-asparaginase resistance in TEL-AML1-negative but not TEL-AML1-positive pediatric acute lymphoblastic leukemia.

  2005cited by this paper
• Amino acids as regulators of gene expression

  2004cited by this paper
• Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment.

  2004cited by this paper
• Establishment of real-time polymerase chain reaction method for quantitative analysis of asparagine synthetase expression.

  2004cited by this paper
• Amino acids as regulators of gene expression: molecular mechanisms.

  2004cited by this paper
• Molecular Pharmacodynamics in Childhood Leukemia

  2003cited by this paper
• Lack of asparagine depletion in the cerebrospinal fluid after one intravenous dose of PEG-asparaginase: a window study at initial diagnosis of childhood ALL

  2003cited by this paper
• Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+ pediatric ALL.

  2003cited by this paper
• Multiple adaptive mechanisms affect asparagine synthetase substrate availability in asparaginase-resistant MOLT-4 human leukaemia cells.

  2001cited by this paper
• Asparagine synthetase expression alone is sufficient to induce l-asparaginase resistance in MOLT-4 human leukaemia cells.

  2001influential reference
• A novel method to compensate for different amplification efficiencies between patient DNA samples in quantitative real-time PCR.

  2001cited by this paper
• Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995

  2000cited by this paper
• Activation of the human asparagine synthetase gene by the amino acid response and the endoplasmic reticulum stress response pathways occurs by common genomic elements.

  2000cited by this paper
• Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Münster.

  2000cited by this paper
• Pegylated asparaginase (OncasparTM) in children with ALL: drug monitoring in reinduction according to the ALL/NHL‐BFM 95 protocols

  2000cited by this paper
• TEL/AML1 gene fusion is related to in vitro drug sensitivity for L-asparaginase in childhood acute lymphoblastic leukemia.

  2000cited by this paper
• L-Asparaginase inhibits the rapamycin-targeted signaling pathway.

  1999cited by this paper
• Prognostic significance of early response to a single dose of asparaginase in childhood acute lymphoblastic leukemia.

  1999cited by this paper
• Amino Acid-dependent Control of p70s6k

  1999cited by this paper
• Amino acid-dependent control of p70(s6k). Involvement of tRNA aminoacylation in the regulation.

  1999cited by this paper
• Acute lymphoblastic leukemia.

  1998cited by this paper
• Relation between age, immunophenotype and in vitro drug resistance in 395 children with acute lymphoblastic leukemia–implications for treatment of infants

  1998cited by this paper
• Unphysiological effects contributing to asparaginase toxicity in vitro.

  1998cited by this paper
• In vitro cellular drug resistance and prognosis in newly diagnosed childhood acute lymphoblastic leukemia.

  1997cited by this paper
• Amino acid control of asparagine synthetase: relation to asparaginase resistance in human leukemia cells.

  1997cited by this paper
• In Vitro Cellular Drug Resistance and Prognosis in Newly Diagnosed Childhood Acute Lymphoblastic Leukemia

  1997cited by this paper
• TEL/AML-1 dimerizes and is associated with a favorable outcome in childhood acute lymphoblastic leukemia.

  1996cited by this paper
• Monitoring of asparaginase activity and asparagine levels in children on different asparaginase preparations.

  1996cited by this paper
• High cure rate with a moderately intensive treatment regimen in non-high-risk childhood acute lymphoblastic leukemia. Results of protocol ALL VI from the Dutch Childhood Leukemia Study Group.

  1996cited by this paper
• Mononuclear cells contaminating acute lymphoblastic leukaemic samples tested for cellular drug resistance using the methyl-thiazol-tetrazolium assay.

  1994cited by this paper
• Molecular and genetic characterization of human cell lines resistant tol-asparaginase and albizziin

  1990influential reference
• In vitro drug sensitivity of cells from children with leukemia using the MTT assay with improved culture conditions.

  1990cited by this paper
• Characterization of polyethylene glycol-modified L-asparaginase from Escherichia coli and its application to therapy of leukemia.

  1986cited by this paper
• Influence of intensive asparaginase in the treatment of childhood non-T-cell acute lymphoblastic leukemia.

  1983cited by this paper
• Acute lymphoblastic leukemia.

  1982cited by this paper
• L-Asparaginase: discovery and development as a tumor-inhibitory agent.

  1981cited by this paper
• L-asparaginase: clinical, biochemical, pharmacological, and immunological studies.

  1971cited by this paper
• l-asparaginase resistance in human leukemia--asparagine synthetase.

  1969cited by this paper
• Asparagine Synthetase Activity of Mouse Leukemias

  1968cited by this paper

• l‐Asparaginase Bio‐Betters: Insight Into Current Formulations, Optimization Strategies and Future Bioengineering Frontiers in Anti‐Cancer Drug Development

  2024cites this paper
• Asparagine transport through SLC1A5/ASCT2 and SLC38A5/SNAT5 is essential for BCP‐ALL cell survival and a potential therapeutic target

  2024cites this paper
• Cancer Therapies Targeting Cellular Metabolism.

  2024cites this paper
• Biochemical Markers of Tumor Cell Sensitivity to L-Asparaginase

  2023cites this paper
• GSK3α Regulates Temporally Dynamic Changes in Ribosomal Proteins upon Amino Acid Starvation in Cancer Cells

  2023cites this paper
• Mesenchymal Stromal Cells (MSCs): An Ally of B-Cell Acute Lymphoblastic Leukemia (B-ALL) Cells in Disease Maintenance and Progression within the Bone Marrow Hematopoietic Niche

  2022cites this paper
• Supramolecular assembly of GSK3α as a cellular response to amino acid starvation.

  2022cites this paper
• The Role of Amino Acids in the Crosstalk Between Mesenchymal Stromal Cells and Neoplastic Cells in the Hematopoietic Niche

  2021cites this paper
• ALL blasts drive primary mesenchymal stromal cells to increase asparagine availability during asparaginase treatment

  2021cites this paper
• Association of allele-specific methylation of the ASNS gene with asparaginase sensitivity and prognosis in T-ALL

  2021cites this paper
• Insights on Metabolic Reprogramming and Its Therapeutic Potential in Acute Leukemia

  2021cites this paper
• Pseudomonas aeruginosa recombinant L-asparaginase: large scale production, purification, and cytotoxicity on THP-1, MDA-MB-231, A549, Caco2 and HCT-116 cell lines.

  2021cites this paper
• Association of aberrant ASNS imprinting with asparaginase sensitivity and chromosomal abnormality in childhood BCP-ALL.

  2020cites this paper
• Dietary Approaches to Cancer Therapy.

  2020cites this paper
• Early precursor T-cell acute lymphoblastic leukemia: current paradigms and evolving concepts

  2020cites this paper
• Highly efficient Pyrococcus furiosus recombinant L-asparaginase with no glutaminase activity: Expression, purification, functional characterization, and cytotoxicity on THP-1, A549 and Caco-2 cell lines.

  2020cites this paper
• Synthetic Lethality of Wnt Pathway Activation and Asparaginase in Drug-Resistant Acute Leukemias

  2019cites this paper
• Targeting extracellular nutrient dependencies of cancer cells

  2019cites this paper
• Gene expression of ASNS, LGMN and CTSB is elevated in a subgroup of childhood BCP-ALL with PAX5 deletion.

  2019cites this paper
• Erythrocyte-encapsulated asparaginase (eryaspase) combined with chemotherapy in second-line treatment of advanced pancreatic cancer: An open-label, randomized Phase IIb trial.

  2019cites this paper
• Asparagine synthetase expression is associated with the sensitivity to asparaginase in extranodal natural killer/T-cell lymphoma in vivo and in vitro

  2018cites this paper
• Asparaginase activity levels and monitoring in patients with acute lymphoblastic leukemia

  2018cites this paper
• Synthetic Lethality of Wnt Pathway Activation and Asparaginase in Drug-Resistant Acute Leukemias

  2018cites this paper
• Targeting Metabolism for Cancer Therapy.

  2017cites this paper
• Asparaginase pharmacology: challenges still to be faced

  2017cites this paper
• The why and how of amino acid analytics in cancer diagnostics and therapy.

  2017cites this paper
• Loss of asparagine synthetase suppresses the growth of human lung cancer cells by arresting cell cycle at G0/G1 phase

  2016cites this paper
• Synergistic Cytotoxic Effect of L-Asparaginase Combined with Decitabine as a Demethylating Agent in Pediatric T-ALL, with Specific Epigenetic Signature

  2016cites this paper
• A clinically attainable dose of L‐asparaginase targets glutamine addiction in lymphoid cell lines

  2015cites this paper
• Asparaginase Therapy in Pediatric Acute Lymphoblastic Leukemia: A Focus on the Mode of Drug Resistance.

  2015cites this paper
• Asparagine Synthetase Expression and Phase I Study With L-Asparaginase Encapsulated in Red Blood Cells in Patients With Pancreatic Adenocarcinoma

  2015cites this paper
• Polymorphisms in GRIA1 gene are a risk factor for asparaginase hypersensitivity during the treatment of childhood acute lymphoblastic leukemia

  2015cites this paper
• ALERGIJSKA REAKCIJA NA L - ASPARAGINAZU I ISHOD LIJEČENJA AKUTNE LIMFOBLASTIČNE LEUKEMIJE KOD DJECE

  2015influential citation
• Glutaminase activity determines cytotoxicity of L-asparaginases on most leukemia cell lines.

  2015cites this paper
• Expression of asparagine synthetase predicts in vitro response to l-asparaginase in canine lymphoid cell lines

  2014cites this paper
• Deficiency in asparagine synthetase expression in rectal cancers receiving concurrent chemoradiotherapy: negative prognostic impact and therapeutic relevance

  2014cites this paper
• Update on the Use of l-Asparaginase in Infants and Adolescent Patients with Acute Lymphoblastic Leukemia

  2014cites this paper
• Expression levels of ASNS in mesenchymal stromal cells in childhood acute lymphoblastic leukemia

  2014cites this paper
• Asparagine synthetase (ASNS) gene polymorphism is associated with the outcome of childhood acute lymphoblastic leukemia by affecting early response to treatment.

  2014cites this paper
• Asparagine synthetase: regulation by cell stress and involvement in tumor biology.

  2013cites this paper
• treating acute myeloid leukemia Inhibiting glutamine uptake represents an attractive new strategy for

  2013cites this paper
• Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia.

  2013influential citation
• Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma

  2013cites this paper
• Asparaginases: biochemical pharmacology and modes of drug resistance.

  2012cites this paper
• Asparagine and aspartic acid concentrations in bone marrow versus peripheral blood during Berlin–Frankfurt–Münster-based induction therapy for childhood acute lymphoblastic leukemia

  2012cites this paper
• Low expression of asparagine synthetase in lymphoid blasts precludes its role in sensitivity to L-asparaginase.

  2012cites this paper
• Expanding targets for a metabolic therapy of cancer: L-asparaginase.

  2012cites this paper
• Erwinia asparaginase in pediatric acute lymphoblastic leukemia

  2012cites this paper
• Genomics and cancer drug resistance.

  2012cites this paper
• Asparaginases: A Successful Class of Drugs Against Leukemias and Lymphomas

  2011cites this paper
• Asparagine Synthetase Is Partially Localized to the Plasma Membrane and Upregulated by L-asparaginase in U 937 Cells *

  2011cites this paper
• Asparaginase in the management of adult acute lymphoblastic leukaemia: is it used appropriately?

  2011cites this paper
• Cancer-stromal interactions

  2011cites this paper
• Asparagine synthetase is partially localized to the plasma membrane and upregulated by L-asparaginase in U937 cells

  2011cites this paper
• Inhibition, characterization, and crystallization of glutamine-dependent asparagine synthetase

  2010cites this paper
• Tolerability and Efficacy of L-Asparaginase Therapy in Pediatric Patients With Acute Lymphoblastic Leukemia

  2010cites this paper
• Long-term results of Dutch Childhood Oncology Group studies for children with acute lymphoblastic leukemia from 1984 to 2004

  2010cites this paper
• Functional analysis of a novel DNA polymorphism of a tandem repeated sequence in the asparagine synthetase gene in acute lymphoblastic leukemia cells.

  2009cites this paper
• Comparison of Native E. coli and PEG Asparaginase Pharmacokinetics and Pharmacodynamics in Pediatric Acute Lymphoblastic Leukemia

  2009cites this paper
• A dyad of lymphoblastic lysosomal cysteine proteases degrades the antileukemic drug L-asparaginase.

  2009cites this paper
• Development of high-throughput mass spectrometry-based approaches for cancer biomarker discovery and implementation.

  2009cites this paper
• Pharmacokinetic, pharmacodynamic and intracellular effects of PEG-asparaginase in newly diagnosed childhood acute lymphoblastic leukemia: results from a single agent window study

  2008cites this paper
• Correlation between asparaginase sensitivity and asparagine synthetase protein content, but not mRNA, in acute lymphoblastic leukemia cell lines

  2008cites this paper
• Mass spectrometric quantification of asparagine synthetase in circulating leukemia cells from acute lymphoblastic leukemia patients.

  2008cites this paper
• Nitrogen metabolism of asparagine and glutamate in Vero cells studied by 1H/15N NMR spectroscopy

  2007cites this paper
• Clinical Pharmacology of Asparaginases in the United States: Asparaginase Population Pharmacokinetic and Pharmacodynamic (PK-PD) Models (NONMEM) in Adult and Pediatric ALL Patients

  2007cites this paper
• Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase.

  2007cites this paper
• An inhibitor of human asparagine synthetase suppresses proliferation of an L-asparaginase-resistant leukemia cell line.

  2006cites this paper
• Role of Glutamine Depletion in Directing Tissue-specific Nutrient Stress Responses to L-Asparaginase*

  2006cites this paper